A genetic compensatory mechanism regulated by Jun and Mef2d modulates the expression of distinct class IIa Hdacs to ensure peripheral nerve myelination and repair.
Sergio Velasco-AvilesNikiben PatelAngeles Casillas-BajoLaura Frutos-RincónEnrique VelascoJuana GallarPeter Arthur-FarrajJosé Antonio Gómez-SánchezHugo CabedoPublished in: eLife (2022)
The class IIa histone deacetylases (HDACs) have pivotal roles in the development of different tissues. Of this family, Schwann cells express Hdac4 , 5 , and 7 but not Hdac9 . Here, we show that a transcription factor regulated genetic compensatory mechanism within this family of proteins, blocks negative regulators of myelination ensuring peripheral nerve developmental myelination and remyelination after injury. Thus, when Hdac4 and 5 are knocked-out from Schwann cells in mice, a JUN-dependent mechanism induces the compensatory overexpression of Hdac7 permitting, although with a delay, the formation of the myelin sheath. When Hdac4 , 5 , and 7 are simultaneously removed, the myocyte-specific enhancer-factor d (MEF2D) binds to the promoter and induces the de novo expression of Hdac9 , and although several melanocytic lineage genes are misexpressed and Remak bundle structure is disrupted, myelination proceeds after a long delay. Thus, our data unveil a finely tuned compensatory mechanism within the class IIa Hdac family, coordinated by distinct transcription factors, that guarantees the ability of Schwann cells to myelinate during development and remyelinate after nerve injury.
Keyphrases
- peripheral nerve
- transcription factor
- histone deacetylase
- induced apoptosis
- cell cycle arrest
- poor prognosis
- genome wide
- dna methylation
- gene expression
- dna binding
- oxidative stress
- binding protein
- genome wide identification
- cell proliferation
- copy number
- adipose tissue
- long non coding rna
- big data
- deep learning
- high fat diet induced